2022 - Research.com Immunology in France Leader Award
2011 - Member of Academia Europaea
Wolf H. Fridman mainly investigates Immunology, Immune system, Tumor microenvironment, Cancer research and Cytotoxic T cell. His research on Immunology often connects related topics like Receptor. The Immune system study combines topics in areas such as Inflammation and Antigen.
Tumor microenvironment is a subfield of Cancer that Wolf H. Fridman explores. His Cancer research research incorporates themes from Immunohistochemistry and Colorectal cancer. His Chemokine research includes elements of Tumor progression, B cell, Cell type and Immunity.
Wolf H. Fridman focuses on Immunology, Molecular biology, Immune system, Receptor and Antibody. He regularly links together related areas like Cytotoxic T cell in his Immunology studies. While the research belongs to areas of Molecular biology, he spends his time largely on the problem of Antigen, intersecting his research to questions surrounding Antigen presentation.
His research integrates issues of Cancer and Cancer research, Stromal cell in his study of Immune system. His studies in Cancer integrate themes in fields like Inflammation and Oncology. Wolf H. Fridman has researched Cancer research in several fields, including Immune checkpoint, Cell, Immunohistochemistry, Tumor progression and Colorectal cancer.
His scientific interests lie mostly in Cancer research, Immune system, Tumor microenvironment, Internal medicine and Cancer. His Cancer research research integrates issues from Inflammation, Colorectal cancer, Complement system and Antigen presentation. His Immune system research is multidisciplinary, incorporating perspectives in Cell and Cytotoxic T cell.
His research in Tumor microenvironment intersects with topics in Immunohistochemistry, Precision medicine, Stromal cell, T cell and Sarcoma. His biological study deals with issues like Classical complement pathway, which deal with fields such as Tumor growth. His Immunotherapy research is classified as research in Immunology.
His primary scientific interests are in Immune system, Tumor microenvironment, Cancer research, Cytotoxic T cell and Immunotherapy. His work deals with themes such as Oncology, Colorectal cancer and Internal medicine, Stromal cell, which intersect with Immune system. His research links Immunology with Internal medicine.
Wolf H. Fridman has included themes like Transcriptome and Cell type in his Stromal cell study. His studies deal with areas such as Inflammation, Cancer and T cell as well as Cancer research. The study incorporates disciplines such as CD8, Pathology, Immunophenotyping, Adjuvant therapy and CD20 in addition to Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman;Franck Pagès;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Jérôme Galon.
Nature Reviews Cancer (2012)
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.
Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Marie Tosolini;Marie Tosolini;Marie Tosolini;Amos Kirilovsky;Amos Kirilovsky;Amos Kirilovsky.
Immunity (2013)
Immune infiltration in human tumors: a prognostic factor that should not be ignored.
Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E.
Oncogene (2010)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages;Amos Kirilovsky;Bernhard Mlecnik;Martin Asslaber.
Journal of Clinical Oncology (2009)
The immune contexture in cancer prognosis and treatment
Wolf H Fridman;Wolf H Fridman;Wolf H Fridman;Laurence Zitvogel;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Guido Kroemer.
Nature Reviews Clinical Oncology (2017)
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Marie-Agnès Dragon-Durey;Chantal Loirat;Sylvie Cloarec;Marie-Alice Macher.
Journal of The American Society of Nephrology (2005)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Cécile Badoual;Stéphane Hans;José Rodriguez;Severine Peyrard.
Clinical Cancer Research (2006)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht;Nicolas A. Giraldo;Nicolas A. Giraldo;Nicolas A. Giraldo;Laetitia Lacroix;Laetitia Lacroix;Laetitia Lacroix;Bénédicte Buttard;Bénédicte Buttard;Bénédicte Buttard.
Genome Biology (2016)
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes.
S Amigorena;C Bonnerot;Drake;D Choquet.
Science (1992)
The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation
Marc Daëron;Sylvain Latour;Odile Malbec;Eric Espinosa.
Immunity (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Institut Pasteur
Université Paris Cité
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Inserm : Institut national de la santé et de la recherche médicale
Université Paris Cité
PSL University
Sorbonne University
Institut Imagine
Inserm : Institut national de la santé et de la recherche médicale
Publications: 145
Inserm : Institut national de la santé et de la recherche médicale
Publications: 57
University of Oulu
Rutgers, The State University of New Jersey
The University of Texas at Dallas
Shanghai Jiao Tong University
Texas A&M University
University of Cambridge
Florey Institute of Neuroscience and Mental Health
Lamont-Doherty Earth Observatory
Louisiana State University
Pennsylvania State University
Shizuoka University
University of Virginia
University of Arkansas for Medical Sciences
Washington University in St. Louis
Tufts Medical Center
University of Leeds